INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 261
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Wisp

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Convenient discreet women's health and wellness, weight and menopause care, pickup/free delivery.

Audienceread

Our read: Convenient discreet women's health and wellness, weight and menopause care, pickup/free delivery.

Pricing & termspartial

Branded GLP-1 prescription care $99/month plus local medication cost. Compounded sublingual semaglutide $225/month.

Clinical relationshipspartial

Hemlock Medical entities in CA, Kansas, NJ and Texas, Beluga Health P.A., SteadyMD LLC roster. Junction/OpenLoop diagnostic consent not universal GLP prescriber.

Pharmacy & fulfillmentpartial

Unnamed mail-order pharmacy partners or local pharmacy choice; local drug cost separate.

Advertising snapshotsnapshot

Channel-specific public-library evidence below; counts are observations, never spend/performance.

Founding yearpartial

2018 (LinkedIn company listing)

Foundersverified

Matthew Swartz.

Location & entity contextpartial

San Francisco, California (LinkedIn headquarters listing, not audited operational location)

Search visibility samplesnapshot

Public first-party program page found and read. Rankings, traffic, index totals and authority not measured.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.